MicroRNA-31-5p promotes vascular remodeling by modulating smooth muscle cell activity via STK40

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Katrin Kalies

University Hospital Halle (Saale), Halle (Germany)

7 More presentations in this session

Presentation thumbnail

PI3Ka protects against arteriosclerosis progression and plaque instability by controlling vascular smooth muscle cell functions

Doctor M. Zierden (Cologne, DE)

Abstract Slides Video

Presentation thumbnail

VasCraft: new decellularized and re-endothelialized human vascular graft produced by tissue engineering for use in arterial bypass

Mrs G. Iraola Picornell (Badalona, Barcelona, ES)

Abstract Slides Video

Presentation thumbnail

Dapagliflozin suppresses vascular smooth muscle cell senescence by promoting autophagy

Doctor H. Yang (Changsha, CN)

Abstract Slides Video

Presentation thumbnail

Evidence from normal human arteries: IRF7 triggers atherosclerosis by enhancing vascular smooth muscle cells inflammation

Doctor S. Cheng (Nanjing, CN)

Abstract Slides Video

Presentation thumbnail

Mass spectrometry-based proteomics identifies high glucose-induced changes in vascular smooth muscle (VSMCs) and sustained extracellular signal-regulated kinases (ERK) activation

Mrs R. Aldahhasi (Leicester, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Molecular drivers of vascular remodelling: from atherosclerosis to aneurysm therapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Session

Novel insights into vascular remodelling

Congress Session

Young Investigator Awards Session in Basic Science

Congress Session

Experimental studies in coronary atherosclerosis disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources